Track 4: Metabolic Liver Disease (MASLD / MASH)

Metabolic Liver Disease explores liver disorders associated with metabolic dysfunction, including metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). Topics include hepatic insulin resistance, liver fat accumulation, inflammation, fibrosis, biomarkers, disease progression, and emerging therapies. This track highlights the relationship between liver health and systemic metabolic disorders, including the bidirectional links between MASLD, type 2 diabetes, obesity, and cardiovascular disease.

 

    Related Conference of Track 4: Metabolic Liver Disease (MASLD / MASH)

    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    October 22-23, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    February 18-19, 2027

    7th International conference on Healthcare Summit

    Singapore City, Singapore
    February 25-26, 2027

    20th International Summit on Diabetes

    London, UK
    March 23-24, 2027

    7th Annual Summit on Diabetes and Endocrinology

    Paris, France
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    July 08-09, 2027

    35th European Diabetes Congress

    Toronto, Canada
    July 15-16, 2027

    7th International conference on Diabetic complications

    Barcelona, Spain

    Track 4: Metabolic Liver Disease (MASLD / MASH) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in